Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Evaluating the Safety, Efficacy and Patient Acceptability of Intravitreal Fluocinolone Acetonide (0.2mcg/Day) Implant in the Treatment of Non-Infectious Uveitis Affecting the Posterior Segment

Laura R Steeples,1,2 Sasa Pockar,1 Nicholas P Jones,1,2 Inês Leal3,4 1Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; 2Faculty of Biology, Medicine & Health, University of Manchester, Ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Steeples LR, Pockar S, Jones NP, Leal I
Format: article
Language:EN
Published: Dove Medical Press 2021
Subjects:
fluocinolone acetonide implant
non-infectious uveitis
posterior segment
efficacy
safety
Ophthalmology
RE1-994
Online Access:https://doaj.org/article/67b04b7854c04221a490dc443f4e7674
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/67b04b7854c04221a490dc443f4e7674

Similar Items